TNFα Is Required for Late BRB Breakdown in Diabetic Retinopathy, and Its Inhibition Prevents Leukostasis and Protects Vessels and Neurons from Apoptosis
Author(s) -
Huang Hu,
Jarel K. Gandhi,
Xiufeng Zhong,
Yanhong Wei,
Junsong Gong,
Elia J. Duh,
Stanley A. Vinores
Publication year - 2011
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.10-5768
Subject(s) - leukostasis , inflammation , apoptosis , tumor necrosis factor alpha , diabetic retinopathy , medicine , diabetes mellitus , retinal , streptozotocin , tunel assay , retina , immunology , endocrinology , biology , ophthalmology , neuroscience , biochemistry , immunohistochemistry
Blood-retinal barrier [BRB] breakdown, characteristic of diabetic retinopathy (DR), is believed to depend on inflammation and apoptosis. Retinal inflammation is almost completely suppressed in the absence of TNFα, which is also associated with apoptosis. This study was conducted to determine the role of TNFα in these diabetic complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom